EPISODE · May 29, 2018 · 16 MIN
CEO Dr. Mark Day of Bioasis Technologies Inc. (OTCQB: BIOAF)
from Stock Day Media · host Stock Day Media
CEO Dr. Mark Day of Bioasis Technologies Inc. (OTCQB: BIOAF), joins Stock Day to give details on developing xB3 for treatment of brain cancer and neurodegenerative disease. OTCQB: BIOAF # biopharmaceutical company developing xB3 # proprietary platform technology # disease-modifying treatments # Alzheimer’s and Huntington’s # blood-brain barrier (BBB) # brain cancers and neurodegenerative diseases # Canada # Glioblastoma # Parkinson’s # treatment of CNS disorders # Vancouver Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
What this episode covers
CEO Dr. Mark Day of Bioasis Technologies Inc. (OTCQB: BIOAF), joins Stock Day to give details on developing xB3 for treatment of brain cancer and neurodegenerative disease. OTCQB: BIOAF # biopharmaceutical company developing xB3 # proprietary platform technology # disease-modifying treatments # Alzheimer’s and Huntington’s # blood-brain barrier (BBB) # brain cancers and neurodegenerative diseases # Canada # Glioblastoma # Parkinson’s # treatment of CNS disorders # Vancouver Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
NOW PLAYING
CEO Dr. Mark Day of Bioasis Technologies Inc. (OTCQB: BIOAF)
No transcript for this episode yet
Similar Episodes
Sep 22, 2023 ·20m
Sep 22, 2023 ·20m
Sep 22, 2023 ·27m
Sep 22, 2023 ·14m
Sep 22, 2023 ·24m
Sep 22, 2023 ·22m